Patents by Inventor Anette Sams Nielsen

Anette Sams Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for use in inducing myocardial perfusion recovery
    Patent number: 11890324
    Abstract: A calcitonin gene-related peptide (CGRP) compound can be selected from N-alpha-[2-(2-{2-[(S)-4-carboxy-4-(17-carboxyheptadecanoylamino)-butyrylamino]ethoxy}ethoxy)acetyl][Ser1]alpha-human CGRP peptide (?-CGRP-analogue), or derivatives thereof; or N-alpha-[2-(2-{2-[(S)-4-carboxy-4-(17-carboxyheptadecanoylamino)butyryl-amino]-ethoxy}ethoxy)acetyl][Ser1]beta-human CGRP peptide (?-CGRP-analogue), or derivatives thereof. The CGRP compound can be used to induce myocardial perfusion recovery, in connection with AMI, by activating any CGRP family of receptors with a larger CGRP compound: CGRP potency ratio in the coronary artery than in the mesenteric artery.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: February 6, 2024
    Assignee: Epoqe Pharma ApS
    Inventors: Anette Sams Nielsen, Lars Ingvar Herbert Edvinsson
  • COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY
    Publication number: 20220031809
    Abstract: A calcitonin gene-related peptide (CGRP) compound can be selected from N-alpha-[2-(2-{2-[(S)-4-carboxy-4-(17-carboxyheptadecanoylamino)-butyrylamino]ethoxy}ethoxy)acetyl][Ser1]alpha-human CGRP peptide (?-CGRP-analogue), or derivatives thereof; or N-alpha-[2-(2-{2-[(S)-4-carboxy-4-(17-carboxyheptadecanoylamino)butyryl-amino]-ethoxy]ethoxy}acetyl][Ser1]beta-human CGRP peptide (?-CGRP-analogue), or derivatives thereof. The CGRP compound can be used to induce myocardial perfusion recovery, in connection with AMI, by activating any CGRP family of receptors with a larger CGRP compound: CGRP potency ratio in the coronary artery than in the mesenteric artery.
    Type: Application
    Filed: December 20, 2019
    Publication date: February 3, 2022
    Inventors: Anette Sams Nielsen, Lars Ingvar Herbert Edvinsson
  • Derivatives of CGRP
    Patent number: 8835379
    Abstract: Acylated CGRP compounds with a linker have prolonged action and are valuable as medicaments.
    Type: Grant
    Filed: October 27, 2010
    Date of Patent: September 16, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Anette Sams Nielsen, Thomas Kruse, Janos Tibor Kodra, Jesper F. Lau, Jacob Kofoed, Kirsten Raun, Cecilia Nilsson
  • Derivatives of CGRP
    Publication number: 20120245083
    Abstract: Acylated CGRP compounds with a linker have prolonged action and are valuable as medicaments.
    Type: Application
    Filed: October 27, 2010
    Publication date: September 27, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Anette Sams Nielsen, Thomas Kruse, Janos Tibor Kodra, Jesper F. Lau, Jacob Kofoed, Kirsten Raun, Cecilia Nilsson
  • GLP-2 compounds, formulations, and uses thereof
    Patent number: 7411039
    Abstract: The present invention relates to novel human glucagon-like peptide-2 (GLP-2) peptides and human glucagon-like peptide-2 derivatives which have a protracted profile of action as well as polynucleotide constructs encoding such peptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: August 12, 2008
    Assignee: Novo Nordisk A/S
    Inventors: Lars Thim, Susanne Bang, Niels Christian Kaarsholm, Anette Sams Nielsen, Nils Langeland Johansen, Kjeld Madsen, Magali Zundel, Peter Thygesen, Birgitte Michelsen
  • GLP-2 compounds, formulations, and uses thereof
    Publication number: 20040122210
    Abstract: The present invention relates to novel human glucagon-like peptide-2 (GLP-2) peptides and human glucagon-like peptide-2 derivatives which have a protracted profile of action as well as polynucleotide constructs encoding such peptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: October 14, 2003
    Publication date: June 24, 2004
    Inventors: Lars Thim, Susanne Bang, Morten Schlein, Niels Christian Kaarsholm, Dorthe Kot Engelund, Anette Sams Nielsen, Nils Langeland Johansen, Kjeld Madsen, Magali Zundel, Peter Thygesen